- Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study2022 | Publication without faculty affiliation
- What new can be expected in the near future in anticoagulant treatment?2023 | Third Faculty of Medicine, First Faculty of Medicine
- Will we change the strategy of anticoagulation therapy?2022 | Third Faculty of Medicine
